Pfizer expects to make as much as $22bn from its new Covid pill this year, on top of $37bn it made in 2021 from the vaccine. Pfizer’s Paxlovid currently costs about $530 for a five-day course of the treatment. Merck’s molnupiravir, now approved for use in the U.K., costs about $700. Reportedly, the cost of production for molnupiravir stands at about $17.74. Experts across the board are predicting demand for antiviral drugs will rapidly outpace supply.

  • There has been a transformation within the pharma industry during the last decade.
  • Although they say that patients are first their actions indicate that Wall Street is first.
  • It starts with CEO’s that are over compensated and brainwashing employees to believe their products benefit all of us.
  • Career “pharma employees” are hurting the industry while people who understand the challenges are being driven out of the industry.
  • Phony pharma awards don’t help acknowledge the problems of the industry.